Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Jordan D Berlin

16PUBLICATIONS

151CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classifiedCancer genetics

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (16)

Sort by Publication Date:

|Jun 30, 2025

A First-in-Human Study of Givastomig, a CLDN18.2 and 4-1BB Bispecific Antibody, as Monotherapy in Patients with CLDN18.2-Positive Advanced or Metastatic Solid Tumors.

Geoffrey Ku, Lin Shen, Farshid Dayyani

|Feb 10, 2025

Results of the Phase I/II Study and Preliminary B-cell Gene Signature of Combined Inhibition of Glutamine Metabolism and EGFR in Colorectal Cancer.

Kristen K Ciombor, Seong-Woo Bae, Jennifer G Whisenant

|Sep 05, 2024

Management of Locally Advanced Rectal Cancer: ASCO Guideline Clinical Insights.

Aaron J Scott, Erin B Kennedy, Jordan Berlin

|Aug 08, 2024

Management of Locally Advanced Rectal Cancer: ASCO Guideline.

Aaron J Scott, Erin B Kennedy, Jordan Berlin

|Oct 20, 2023

Enhancing reporting quality and impact of early phase dose-finding clinical trials: CONSORT Dose-finding Extension (CONSORT-DEFINE) guidance.

Christina Yap, Olga Solovyeva, Johann de Bono

|Oct 20, 2023

Enhancing quality and impact of early phase dose-finding clinical trial protocols: SPIRIT Dose-finding Extension (SPIRIT-DEFINE) guidance.

Christina Yap, Jan Rekowski, Moreno Ursino

Pageof 3

Frequent Collaborators

3 joint publications

Erin B Kennedy

2 joint publications

Annick Seithel-Keuth

2 joint publications

Anthony J Olszanski

2 joint publications

Dana Backlund Cardin

2 joint publications

Jan Rekowski

2 joint publications

Howard S Hochster

2 joint publications

Christina Yap

2 joint publications

Alexander Spira

2 joint publications

Clifford Robinson

2 joint publications

Saiama N Waqar

Frequent Collaborators

3 joint publications

Erin B Kennedy

2 joint publications

Annick Seithel-Keuth

2 joint publications

Anthony J Olszanski

2 joint publications

Dana Backlund Cardin

Top Related Videos

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

Published on : May 12, 2023

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on : Feb 12, 2022

See more related videos

Top Related Videos

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

Published on : May 12, 2023

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on : Feb 12, 2022

See more related videos